EGFR and non-small cell lung carcinoma: Exposure of the coculture of human lung non-small cell lung cancer cell line A549 and human fetal lung fibroblast HFL1 cells to the epidermal growth factor receptor EGFR-targeted drug gefitinib showed A549 cell resistance.